Medicare Enrolled

Dr. Margarita Fallena, MD

Rheumatology · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
12740 HILLCREST RD STE 265, Dallas, TX 75230
9725131410
In practice since 2007 (18 years)
NPI: 1760686737 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fallena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fallena? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fallena

Dr. Margarita Fallena is a rheumatology specialist in Dallas, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Fallena performed 5,439 Medicare services across 1,243 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fallena received a total of $5,326 from 28 pharmaceutical and/or device companies across 342 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fallena is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 42% volume in TX $5,326 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,439
Medicare services
Top 42% in TX for rheumatology
1,243
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~302 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,580 $18 $69
Office visit, established patient (30-39 min) 419 $91 $375
Comprehensive metabolic blood panel 400 $10 $31
Complete blood count (CBC) with differential 394 $7 $23
Blood draw (venipuncture) 387 $8 $27
C-reactive protein test (inflammation marker) 311 $5 $15
Sed rate test (inflammation marker) 310 $3 $8
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 219 $59 $218
Urinalysis with microscopic exam 65 $3 $9
Vitamin D level test 50 $29 $88
Measurement of complement (immune system proteins), antigen, 48 $12 $36
Measurement of antibody for assessment of autoimmune disorder, any method 35 $18 $54
Automated urinalysis 31 $2 $7
Uric acid level test 23 $4 $14
New patient office visit (45-59 min) 22 $113 $491
Measurement of antibody for rheumatoid arthritis assessment 21 $13 $39
Screening test for antibody to noninfectious agent 21 $12 $36
Screening test for autoimmune disorder 19 $12 $36
Rheumatoid factor level 19 $6 $17
Office visit, established patient, complex (40-54 min) 15 $140 $530
Flu vaccine administration 14 $31 $80
Thyroid stimulating hormone (TSH) test 13 $16 $48
Flu vaccine, high-dose 12 $72 $587
Hepatitis c antibody measurement 11 $14 $43
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,326
Total received (2018-2024)
Avg $761/year across 7 years
Top 45% in TX for rheumatology
28
Companies
342
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,326 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,044
2023
$256
2022
$93
2021
$182
2020
$157
2019
$1,051
2018
$1,543

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$885
ABBVIE INC.
$823
Novartis Pharmaceuticals Corporation
$811
AbbVie, Inc.
$622
Janssen Biotech, Inc.
$494
Amgen Inc.
$386
GlaxoSmithKline, LLC.
$215
UCB, Inc.
$172
GENZYME CORPORATION
$128
Horizon Therapeutics plc
$108
ANI Pharmaceuticals, Inc.
$108
E.R. Squibb & Sons, L.L.C.
$69
Lilly USA, LLC
$65
Alexion Pharmaceuticals, Inc.
$56
Merck Sharp & Dohme Corporation
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Genentech USA, Inc.
$39
Mallinckrodt Enterprises LLC
$34
Aurinia Pharma U.S., Inc.
$30
Horizon Pharma plc
$29
Kiniksa Pharmaceuticals International, plc
$29
Octapharma USA, Inc.
$26
MEDAC PHARMA, INC.
$26
HOSPIRA, INC.
$26
Actelion Pharmaceuticals US, Inc.
$19
AbbVie Inc.
$14
Zimmer Biomet Holdings, Inc.
$14
DePuy Synthes Sales Inc.
$12
Top 3 companies account for 47.3% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · Enbrel · GPS III PLATELET CONCENTRATION SYSTEM · HUMIRA · Humira · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · ORTHOVISC · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · UPTRAVI · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $98 per 100 Medicare services performed
Looking for a rheumatology specialist in Dallas?
Compare rheumatologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
98
Per 100K population
3.8
County median income
$74,149
Nearest hospital
MEDICAL CITY DALLAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Fallena is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Fallena experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Fallena performed 2,580 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fallena receive payments from pharmaceutical companies?
Yes. Dr. Fallena received a total of $5,326 from 28 companies across 342 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fallena's costs compare to other rheumatologists in Dallas?
Dr. Fallena's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fallena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →